Resumen
Several recent studies have tried to characterize the effects of a lower-than-usual target blood pressure on progression of nondiabetic kidney disease. An observational study, the Modification of Diet in Renal Disease Study, showed long-term benefit. The randomized African-American Study of Kidney Disease and Hypertension showed no benefit, nor did the recently published Ramipril Efficacy in Nephropathy 2 Trial. Here's our take on these conflicting study results.
| Idioma original | English (US) |
|---|---|
| Páginas (desde-hasta) | 79-81 |
| Número de páginas | 3 |
| Publicación | Annals of internal medicine |
| Volumen | 143 |
| N.º | 1 |
| DOI | |
| Estado | Published - jul 5 2005 |
| Publicado de forma externa | Sí |
ASJC Scopus subject areas
- Internal Medicine
Huella
Profundice en los temas de investigación de 'An editorial update: What level of blood pressure control in chronic kidney disease?'. En conjunto forman una huella única.Citar esto
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS